People

Biopharmaceutical executive and Circular Genomics scientific adviser identified in its dated appointment release as Michael F. Ackermann. His background includes Eli Lilly, Quintiles and Arrivo BioVentures; holds an immunology PhD from Drexel and an MBA from UNC. This identity is preserved separately from the native same-name Vensana/Oculeve medtech adviser.